¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sustained action drugs"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® parenteral administration of drugs ÇÑ±Û ºñ°æ±¸Àû ¾àǰÅõ¿©
¼³¸í   
  ÀÔÀ» ÅëÇÏÁö ¾Ê´Â ´Ù¾çÇÑ ¾àǰÅõ¿© ¹æ¹ýÀ» ¸»ÇÔ. ÁÖ»ç±â¸¦ ÀÌ¿ëÇÑ´Ù.
  
  1)ÇÇÇÏÁÖ»ç: subcutaneous injection-ÇǺΠ¹ØÀ¸·Î ÁÖ»çÇϴ °Í. ´ë°³ ÆÈÀÇ Áß°£ºÎ¿¡ ÁÖ»çÇÑ´Ù.
  
  2)ÁøÇdz»ÁÖ»ç: intradermal injection-¾ã°Ô Âñ·¯¼­ ÁøÇdz»¿¡ ÁÖ»çÇÑ´Ù. ÁַΠ¾Ë·¯Áö È¯ÀÚÀÇ Ç׿ø°Ë»ç¿¡ ÀÌ¿ëÇÑ´Ù.
  
  3)±ÙÀ°³»ÁÖ»ç: intramuscular injection-À§ÆÈÀ̳ª, È¤Àº ¾ûµ¢ÀÌ ºÎÀ§¿¡ ÁÖ»çÇÑ´Ù. À̰ÍÀº ÁַΠÇǺο¡ ÀÚ±ØÀÌ ½ÉÇÑ ¾àÁ¦³ª È¤Àº ÃµÃµÈ÷ ÀÛ¿ëÇϴ ¾àÁ¦¸¦ ¸¹ÀÌ ÁÖ»çÇÒ ¶§ »ç¿ëÇÑ´Ù.
  
  4)Ç÷°üÁÖ»ç: intravenous(IV) injection-Á¤¸ÆÀ» ÅëÇØ ÁÖ»çÇÑ´Ù. ¾î´À Á¤¸ÆÀ̳ª °¡´ÉÇÏÁö¸¸, ´ë°³ ÆÈ¶ÒÀ̳ª ¹ß µîÀÇ Á¤¸ÆÀ» ÀÌ¿ëÇÑ´Ù. ºü¸¥ Ä¡·áÈ¿°ú¸¦ º¸±â À§ÇØ »ç¿ëÇÑ´Ù. À̶§ ÇǺο¡ ÀÚ±ØÀ» Áִ ¾àÁ¦À̸é, »õÁö ¾Êµµ·Ï Á¶½ÉÇØ¾ß ÇÑ´Ù.
  
  5) ¼ö¸·°­³»ÁÖ»ç: intrathecal injection-µÎ°³³ª Ã´¼ö°­³»¿¡ ÁÖ»çÇÒ ¶§ ÀÌ¿ëÇÑ´Ù.
  
  6)°­³»ÁÖ»ç: intracavitary injection-°ø°£À¸·Î µÈ ºÎÀ§¿¡ ÁÖ»çÇÑ´Ù. ¿¹¸¦ µé¾î º¹ºÎ°ø°£À̳ª Èä°­³»¿¡ ÁÖ»çÇÏ¿© »ç¿ëÇÑ´Ù.
¿µ¹® bacteriocidal action ÇÑ±Û »ì±ÕÀÛ¿ë
¼³¸í   
  È­Çпä¹ýÁ¦, ¼Òµ¶Á¦ Áß¿¡´Â ¹Ì»ý¹°À» »ç¸ê½Ã۴ ÀÛ¿ëÀÌ ÀÖ´Ù. À̰ÍÀ» »ì±ÕÀÛ¿ëÀ̶ó°í ÇÑ´Ù. ÀÌ¿¡ ´ëÇØ ¾î¶² ¾àÁ¦¿¡ ÀÇÇØ ±ÕÀÇ Áõ½ÄÀÌ ¾ïÁ¦°¡ µÇ´Âµ¥ ¾àÁ¦¸¦ Á¦°ÅÇϸ頴ٽàÁõ½ÄÇϴ °ÍÀ» Á¤±ÕÀÛ¿ëÀ̶ó ÇÑ´Ù.
¿µ¹® rectal administration of drugs ÇÑ±Û ¾à¹°ÀÇ °ðâÀÚÁ¾à½Ä Åõ¿©
¼³¸í   
  ÀÔÀ» ÅëÇØ ¸ÔÀº ¾à¹°Àº Èí¼öµÈ ÈÄ °£À» °ÅÃÄ º´º¯ºÎÀ§·Î ¿î¹ÝµÈ´Ù. µû¶ó¼­ °£¿¡¼­ ´ë»ç°¡ µÇ¾î ¾à¹°·Î¼­ÀÇ È¿°ú°¡ ¾ø¾îÁú °¡´É¼ºÀÌ ÀÖÀ» »Ó ¾Æ´Ï¶ó °£¿¡ µ¶¼ºÀÛ¿ëÀ» ÀÏÀ¸Å³ ¼öµµ ÀÖ´Ù. ÀÌ·¯ÇÑ ´ÜÁ¡À» º¸¿ÏÇϱâÀ§ÇØ °£À» ÅëÇÏÁö ¾Ê°í À绡¸® Èí¼öµÇ¾î º´º¯À¸·Î °¥ ¼ö Àִ ¹æÆíÀ¸·Î Á÷ÀåÁ¾àÀ» »ç¿ëÇÑ´Ù. Á÷ÀåÀÇ Á¤¸ÆÈ帧Àº °£À» °ÅÄ¡Áö ¾Ê°í Á÷Á¢ ÇÏ´ëÁ¤¸ÆÀ» ÅëÇØ ¿ì½É¹æÀ¸·Î Èê·¯µé±â ¶§¹®ÀÌ´Ù. 
¿µ¹® side effects of drugs ÇÑ±Û ¾à¹°ÀÇ ºÎÀÛ¿ë
¼³¸í   
  ¾àÀ» »ç¿ëÇÒ ¶§ ±â´ëÇϴ ȿ°ú ¿Ü¿¡ ´Ù¸¥ Àå±â¿¡¼­ ³ªÅ¸³ª´Â ¿øÄ¡ ¾Ê´Â È¿°ú¸¦ ÃÑĪÇϴ ¸»ÀÌ´Ù. ¿¹¸¦ µé¾î Ç÷¾ÐÀ» ³·Ãß±â À§ÇØ Ç×°íÇ÷¾ÐÁ¦¸¦ »ç¿ë ½Ã, Ç÷¾ÐÀÌ ¶³¾îÁö´Â µ¿½Ã¿¡ ±â°üÁöÀÇ ¼öÃàÀÌ ÀϾ´Â Çö»ó.
¿µ¹® buffer action ÇÑ±Û ¿ÏÃæÀÛ¿ë
¼³¸í   
  Ç÷¾Ð, pH µî°ú °°ÀÌ »ýüÀÇ ±â´É ¹× »óŸ¦ ¾ÈÁ¤½Ã۰íÀÚ Çϴ ÀÛ¿ë : pH 7ÀΠ¼ø¼öÇÑ ¹°¿¡¼­ ¼Ò·®ÀÇ »ê ¶Ç´Â ¾ËÄ®¸®¸¦ °¡Çϸ頱נ¾ç¿¡ µû¶ó ¹°ÀÇ pH°¡ ¶Ñ·ÇÇϰԠº¯ÇÑ´Ù. ±×·¯³ª ¾àÇÑ »ê°ú ±× ¿°ÀǠȥÇÕ¿ë¾×, ¶Ç´Â ¾àÇÑ »ê±â¿Í ±× ¿°ÀǠȥÇÕ¿ë¾×À¸·Î ÀÌ·ç¾îÁö´Â °è¿¡¼­´Â ¾à°£ÀÇ »ê ¶Ç´Â ¾ËÄ®¸®¸¦ °¡Çصµ ¿ÏÃæÀÛ¿ë ¶§¹®¿¡ pH´Â °ÅÀÇ º¯ÇÏÁö ¾Ê´Â´Ù. ¿¹¸¦ µé¾î, ¾àÇÑ »ê°ú ±× ¿°ÀǠȥÇÕ¿ë¾×À¸·Î ÀÌ·ç¾îÁö´Â °èͧ¿¡ »êÀ» °¡ÇßÀ» ¶§¸¦ »ý°¢Çϸé, »ê¿¡ ÀÇÇØ¼­ °¡ÇØÁø ¼ö¼ÒÀ̿ H+Àº ¾àÇÑ »êÀ̿°ú °áÇÕÇÏ¿© ºñÇØ¸®ÀΠ»êÀÌ µÇ¾î pH°¡ º¯ÇÏÁö ¾Ê´Â´Ù. ¶Ç ¾ËÄ®¸®¸¦ °¡ÇßÀ» ¶§´Â °¡ÇØÁø ¼ö»êÀ̿ OH£­ÀÌ H+°ú °áÇÕÇÏ¿© ¹°À» ¸¸µé°í, ºÎÁ·ÇÑ H+Àº ºñÇØ¸® ¾àÇÑ »êÀÇ ÇØ¸®¿¡ ÀÇÇØ¼­ º¸ÃæµÇ¹Ç·Î½á ¿ª½Ã pH´Â º¯ÇÏÁö ¾Ê´Â´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sustained attention
    Áö¼ÓÀûÁÖÀÇ·Â
  • sustained fever
    Áö¼Ó¿­
  • antifungal action
    Ç×Áø±ÕÀÛ¿ë
  • antimicrobial action
    Ç×±ÕÀÛ¿ë
  • antipyretic action
    ÇØ¿­ÀÛ¿ë
  • action
    1. ÀÛ¿ë 2. Ȱµ¿
  • action current
    Ȱµ¿Àü·ù
  • action potential
    Ȱµ¿ÀüÀ§
  • action tremor
    Ȱµ¿¶³¸²
  • additive action
    ºÎ°¡ÀÛ¿ë
  • adverse action
    À¯ÇØÀÛ¿ë
  • absorption action
    Èí¼öÀÛ¿ë
  • amphoteric action
    ¾çÂÊÀÛ¿ë
  • anabolic action
    ÇÕ¼º´ë»çÀÛ¿ë, µ¿È­ÀÛ¿ë
  • biphasic action potential
    ÀÌ»ó¼ºÈ°µ¿ÀüÀ§
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • action
    ÀÛ¿ë, Ȱµ¿
  • absorption action
    Èí¼öÀÛ¿ë
  • additive action
    ºÎ°¡ÀÛ¿ë
  • adverse action
    À¯ÇØÀÛ¿ë
  • antimicrobial action
    Ç×±ÕÀÛ¿ë
  • antipyretic action
    ÇØ¿­ÀÛ¿ë
  • bacteriocidal action
    »ì±ÕÀÛ¿ë
  • bacteriostatic action
    Á¤±ÕÀÛ¿ë
  • buffer action
    ¿ÏÃæÀÛ¿ë
  • diuretic action
    ÀÌ´¢ÀÛ¿ë
  • inhibitory action
    ¾ïÁ¦ÀÛ¿ë, ÀúÁöÀÛ¿ë
  • pharmacological action
    ¾à¸®ÀÛ¿ë
  • promotor action
    ÃËÁøÀÛ¿ë
  • action potential
    Ȱµ¿ÀüÀ§
  • action tremor
    Ȱµ¿¶³¸²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ill-sustained accommodation
    Á¶Àý¼è¾à
  • sustained attention
    Áö¼ÓÀûÁýÁß·Â
  • sustained fever
    Áö¼Ó¿­
  • action
    Ȱµ¿, ÀÛ¿ë
  • absorption action
    Èí¼öÀÛ¿ë
  • action current
    Ȱµ¿Àü·ù
  • action potential
    Ȱµ¿ÀüÀ§
  • action tremor
    Ȱµ¿¶³¸²
  • additive action
    ºÎ°¡ÀÛ¿ë
  • adverse action
    À¯ÇØÀÛ¿ë
  • amphoteric action
    ¾ç¼ºÀÛ¿ë
  • anabolic action
    µ¿È­ÀÛ¿ë
  • antifungal action
    Ç×Áø±ÕÀÛ¿ë
  • antimicrobial action
    Ç×±ÕÀÛ¿ë
  • antipyretic action
    ÇØ¿­ÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ill-sustained accommodation
    Á¶Àý¼è¾à
  • primary action; main action
    ÁÖÀÛ¿ë, ÀÏÂ÷ÀÛ¿ë.
  • Ganglionic blocking drugs
    ½Å°æÀýÂ÷´Ü¾àÁ¦(ãêÌèï½ó´Ó¨å·ð¥)
  • antimalarial drugs
    Ç׸»¶ó¸®¾ÆÁ¦(ù÷¡­ð¥).
  • galenical preparation =crude drugs
    »ý¾à (ßæå·).
  • hydantoinlike drugs
    È÷´ÜÅäÀξç¾àÁ¦.
  • illict drugs
    ºÒ¹ý¾à¹°
  • poisoning by drugs
    ¾à¹°Áßµ¶(ËâËÑÌ¡ËÄ).
  • poisoning by drugs
    ¾à¹°Áßµ¶(å·ÚªñéÔ¸).
  • HT2 receptors, action of hallucinogens
    5-ÇÏÀ̵å·Ï½ÃÆ®¸³Å¸¹Î2¼ö¿ëü
  • SDA= specific dynamic action
    ƯÀ̵¿Àû ÀÛ¿ë.
  • absorption action
    Èí¼öÀÛ¿ë.
  • action myoclonia
    Ȱµ¿°£´ë¼º ±Ù°æ·Ã(Áõ)(¡­ÊàÓÛàõÐÉÌâÕýñø)
  • action myoclonia
    Ȱµ¿°£´ë¼º ±Ù°æ·Ã(Áõ)(¡­ÊàÓÛàõÐÉÌâÕýñø).
  • action potential
    Ȱµ¿ÀüÀ§(¡­ï³êÈ), Ȱµ¿Àü¾Ð(¡­ï³äâ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sustained action drugs
    ÁöÈ¿¼º ¾àÁ¦(ò¥üùàõ å·ð¥).
  • sustained action drugs
    ÁöÈ¿¼º ¾àÁ¦(ò¥üùàõå·ð¥).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sustained release drugs
    ÁöÈ¿¼º ¾àÁ¦(ò¥üùàõ å·ð¥).
  • sustained release drugs
    ÁöÈ¿¼º ¾àÁ¦(ò¥üùàõå·ð¥).
  • ill-sustained accommodation
    Á¶Àý¼è¾à
  • sustained attention
    Áö¼ÓÀû ÁýÁß·Â(ò¥áÙîÜó¢ñéÕô).
  • sustained fever
    Áö¼Ó¿­(ò¥áÙæð)
  • primary action; main action
    ÁÖÀÛ¿ë, ÀÏÂ÷ÀÛ¿ë.
  • antimalarial drugs
    Ç׸»¶ó¸®¾ÆÁ¦(ù÷¡­ð¥).
  • drugs
    ¾à¹°(å·Úª)
  • drugs,interaction
    »óÈ£ÀÛ¿ë(ßÓû»íÂéÄ)
  • drugs,overdosage
    °ú·®(ΦÕá)
  • drugs,side effects
    ºÎÀÛ¿ë(ÜùíÂéÄ)
  • drugs,therapeutic
    Ä¡·á(Àû)(ö½ÖûîÜ)
  • galenical preparation =crude drugs
    »ý¾à (ßæå·).
  • hydantoinlike drugs
    È÷´ÜÅäÀξç¾àÁ¦.
  • illict drugs
    ºÒ¹ý¾à¹°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • action current
    Ȱµ¿Àü·ù (üÀÔÑï³×µ)
  • action potential
    Ȱµ¿ÀüÀ§ (üÀÔÑï³êÈ)
  • action spectrum
    ÀÛ¿ë(íÂéÄ)½ºÆåÆ®·³
  • calorigenic action
    Ä®·Î¸®»ý¼ºÀÛ¿ë(ßæà÷íÂéÄ)
  • capillary action
    ¸ð¼¼°ü ÀÛ¿ë(Ù¾á¬Î·íÂéÄ)
  • law of mass action
    Áú·®ÀÛ¿ë¹ýÄ¢(òõÕáíÂéÄÛööÎ)
  • mass action
    Áú·®ÀÛ¿ë(òõÕáíÂéÄ)
  • mass-action ratio
    Áú·®ÀÛ¿ëÀ²(òõÕáíÂéÄëÒ)
  • photochemical action spectrum
    ±¤È­ÇÐÀÛ¿ë(ÎÃûùùÊíÂéÄ) ½ºÆåÆ®·³
  • photodynamic action
    ±¤¿ªÇÐ ÀÛ¿ë(ÎÃÕôùÊíÂéÄ)
  • protein-sparing action
    ´Ü¹éÁú Àý¾à ÀÛ¿ë(Ó±ÛÜòõï½å³íÂéÄ)
  • specific dynamic action
    ƯÀÌ µ¿Àû ÀÛ¿ë(÷åì¶ÔÑîÜíÂéÄ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • action
    ÀÛ¿ë, Ȱµ¿, ±â´É
  • adverse action
    À¯ÇØÀÛ¿ë
  • duration (of action)
    Áö¼Ó½Ã°£
  • stop action imaging
    (Ȱµ¿)Á¤Áö»óÅ¿µ»ó
  • synergistic action
    »ó½ÂÀÛ¿ë, Çùµ¿ÀÛ¿ë
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MAP malignant atrophic papulosis; mandibular angle plane; maturation-activated protein; maximal aerobic ...
SA salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame...
DAT delayed-action tablet; dementia Alzheimer's type; dental aptitude test; diacetylthiamine; diet as to...
FAP familial adenomatous polyposis; familial amyloid polyneuropathy; fatty acid polyunsaturated; fatty a...
PA panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ATD Antithyroid drugs
DMARD Disease Modifying Antirheumatic Drugs
NSAID Non Steroid Anti-Inflammatory Drugs
SAARD Slow Acting Anti-Rheumatic Drugs
NSVT Non-sustained ventricular tachycardia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sustained action drug
    ÁöÈ¿¼º ¾àÁ¦
  • sustained release drug
    ÁöÈ¿¼º ¾àÁ¦
  • action mechanism
    ÀÛ¿ë ±âÀü
    ¾î¶² ±â´ÉÀÌ ÀϾ°Ô µÇ´Â °úÁ¤°ú °æ°ú.
  • action onset
    ÀÛ¿ë °³½Ã
  • action potential
    Ȱµ¿ ÀüÀ§, Ȱµ¿ Àü¾Ð
    ±ÙÀ°¼¼Æ÷ ¶Ç´Â ½Å°æ¼¼Æ÷°¡ ÈïºÐÇÒ ¶§ »ý±â´Â Àü±âÀû Ȱ¼ºÀ¸·Î¼­, Àü±âÀû, È­ÇÐÀû, ±â°èÀû ÀÚ±Ø ¹× ¿Âµµº¯È­ µî¿¡ ÀÇÇÏ¿© »ý±ä´Ù°í »ý°¢Çϰí ÀÖ´Ù.
  • action variable
    ÀÛ¿ë º¯¼ö
  • adverse action
    À¯ÇØÀÛ¿ë
  • analgetic action
    ÁøÅë ÀÛ¿ë
  • antagonistic action
    ±æÇ× ÀÛ¿ë
  • antidiuretic action
    Ç×ÀÌ´¢ÀÛ¿ë
  • antimicrobial action
    Ç×±Õ ÀÛ¿ë
  • antinociception action
    Ç×Ä§ÇØ¼ö¿ë¼º ÀÛ¿ë, Ç×À¯ÇØ ¼ö¿ë¼º ÀÛ¿ë
  • antipyretic action
    ÇØ¿­ ÀÛ¿ë
  • antispasmodic action
    Áø°æÀÛ¿ë
  • bactericidal action
    »ì±Õ ÀÛ¿ë, »ì±Õ¼º
    1. ¹ÚÅ׸®¾Æ¸¦ Á×ÀÌ´Â Çö»ó. ÀÌ ¿ë¾î´Â Á¾Á¾ Ç×»ýÁ¦ÀÇ ¼º°ÝÀ» ¼³¸íÇϴµ¥ »ç¿ëµÈ´Ù. 2. È­Çпä¹ýÁ¦, ¼Òµ¶Á¦ Áß¿¡´Â ¹Ì»ý¹°À» ¼Ò¸ê½ÃŰ´Â ÀÛ¿ëÀÌ ÀÖ´Ù. ÀÌ¿¡ ´ëÇØ ¾î¶² ¾àÁ¦¿¡ ´ëÇØ ±ÕÀÇ Áõ½ÄÀÌ ¾ïÁ¦µÇ´Âµ¥ ¾àÁ¦¸¦ Á¦°ÅÇÏ¸é ´Ù½Ã Áõ½ÄÇÏ´Â °ÍÀ» Áõ±Õ ÀÛ¿ëÀ̶ó ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
sustained release tablet A drug product formulation that provides the required dosage initially and then maintains or repeats it at desired intervals.
Synonym: prolonged action tablet, repeat action tablet.
(05 Mar 2000)
sustained yield The maintenance in perpetuity of regular, periodic harvest of wood resources from forest land without damaging the productivity of the land.
(05 Dec 1998)
veterinary drugs Drugs used by veterinarians in the treatment of animal diseases. The veterinarian's pharmacological armamentarium is the counterpart of drugs treating human diseases, with dosage and administration adjusted to the size, weight, disease, and idiosyncrasies of the species. In the united states most drugs are subject to federal regulations with special reference to the safety of drugs and residues in edible animal products.
(12 Dec 1998)
cytotoxic drugs <pharmacology> Anti-cancer drugs which act by killing or preventing the division of cells.
See: chemotherapy.
(13 Nov 1997)
psychotropic drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquillising agents (including the antipsychotics and anti-anxiety agents).
(12 Dec 1998)
neuroleptic drugs Literally nerve seising: used of chlorpromazine like drugs. Antagonise the effects of dopamine.
Origin: Gr. Lepsis = a taking hold
(18 Nov 1997)
street drugs Drugs obtained and often manufactured illegally for the subjective effects they are said to produce. They are often distributed in urban areas, but are also available in suburban and rural areas, and tend to be grossly impure and may cause unexpected toxicity.
(12 Dec 1998)
designer drugs Drugs designed and synthesised, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are mptp (a reverse ester of meperidine), mda (3,4-methylenedioxyamphetamine), and mdma (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.
(12 Dec 1998)
drugs, chinese herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesised compounds manufactured in china.
(12 Dec 1998)
drugs, essential Drugs considered essential to meet the health needs of a population as well as to control drug costs. (world health organization action programme on essential drugs, 1994, p3)
(12 Dec 1998)
drugs, generic Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.
(12 Dec 1998)
drugs, investigational Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (treatment ind). The main heading includes drugs under investigation in foreign countries.
(12 Dec 1998)
drugs, non-prescription Drugs that can be sold legally without a prescription.
(12 Dec 1998)
drugs toxic to lung <radiology> Bleomycin, methotrexate, cytoxan, amiodarone
(12 Dec 1998)
immunosuppressive drugs Drugs that block the bodys ability to fight infection or foreign substances that enter the body. A person receiving an organ transplant is given these drugs to stop the body from rejecting the new organ or tissue. Cyclosporin is a commonly used immunosuppressive drug.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • action
    ¿òÁ÷ÀÓ,Çൿ,µ¿ÀÛ
  • action
    Ȱµ¿;ÀÛ¿ë;Çൿ;ÇàÀ§;µ¿ÀÛ;ÀÛ¿ë;¼Ò¼Û;ÀüÅõ;¼Ò¼³ÀÇ ÁٰŸ® Àü°³
  • civil action
    ¹Î»ç¼Ò¼Û
  • class action
    (°øµ¿ ÇÇÇØÀÚµéÀÇ)Áý´Ü ¼Ò¼Û
  • contact action
    Á¢ÃËÀÛ¿ë
  • covert action(operation)
    (°æÂû.Á¤º¸ºÎÀÇ)ºñ¹Ð°øÀÛ;ºñ¹Ðøº¸È°µ¿
  • cross action
    ¹Ý´ë ¼Ò¼Û;¹Ý¼Ò
  • delaying action
    Áö¿¬ Àü¼ú ÀÇ
  • direct action
    Á÷Á¢ Çൿ ±Ç¸®¸¦ À§ÇÑ ÆÄ¾÷(µ¥¸ð,½Ã¹ÎÀû ÀúÇ× µî)
  • disengaging action
    (±º)±³Àü ȸÇÇ;ÀÚ¹ßÀû ö¼ö
  • evasive action
    (Àü½Ã¿¡ ¼±¹Ú,Ç×°ø±â°¡ ÃëÇÏ´Â)ȸÇÇ Çൿ
  • friendly action
    ¿ìÈ£Àû ¼Ò¼Û
  • industrial action
    ³ëµ¿ÀÚÃøÀÇ ÀïÀÇ ÇàÀ§
  • mass action
    Áú·® ÀÛ¿ë
  • nocover action
    ³ëµ¿ÀïÀÇ ÁßÀÎ Á¶ÇÕ¿ø ¸òÀÇ ÀÏÀ» ÇÏÁö ¾ÊÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á